Awareness of HCV Infection Among Persons Who Inject Drugs in San Diego, California

Bibliographic Data

ID11033101
AuthorsMelissa G Collier (0000-0001-9486-8123, Melissa G. Collier and Eyasu H. Teshale are with the Division of Viral Hepatitis, National Center for HIV, Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA. Sandeep K. Bhaurla, Jazmine Cuevas-Mota, Richard F. Armenta, and Richard S. Garfein are with the Division of Global Public Health, School of Medicine, University of California, San Diego.), Sandeep K Bhaurla (Melissa G. Collier and Eyasu H. Teshale are with the Division of Viral Hepatitis, National Center for HIV, Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA. Sandeep K. Bhaurla, Jazmine Cuevas-Mota, Richard F. Armenta, and Richard S. Garfein are with the Division of Global Public Health, School of Medicine, University of California, San Diego.), Sandeep Bhaurla (National Center for HIV/AIDS Viral Hepatitis STD and TB Prevention), Jazmine Cuevas-Mota (0000-0003-4486-3329, Melissa G. Collier and Eyasu H. Teshale are with the Division of Viral Hepatitis, National Center for HIV, Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA. Sandeep K. Bhaurla, Jazmine Cuevas-Mota, Richard F. Armenta, and Richard S. Garfein are with the Division of Global Public Health, School of Medicine, University of California, San Diego.), Richard F Armenta (0000-0002-1504-3666, Melissa G. Collier and Eyasu H. Teshale are with the Division of Viral Hepatitis, National Center for HIV, Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA. Sandeep K. Bhaurla, Jazmine Cuevas-Mota, Richard F. Armenta, and Richard S. Garfein are with the Division of Global Public Health, School of Medicine, University of California, San Diego.), Eyasu H Teshale (0000-0001-5244-8251, Melissa G. Collier and Eyasu H. Teshale are with the Division of Viral Hepatitis, National Center for HIV, Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA. Sandeep K. Bhaurla, Jazmine Cuevas-Mota, Richard F. Armenta, and Richard S. Garfein are with the Division of Global Public Health, School of Medicine, University of California, San Diego.), RICHARD S GARFEIN (0000-0003-3663-7153, Melissa G. Collier and Eyasu H. Teshale are with the Division of Viral Hepatitis, National Center for HIV, Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA. Sandeep K. Bhaurla, Jazmine Cuevas-Mota, Richard F. Armenta, and Richard S. Garfein are with the Division of Global Public Health, School of Medicine, University of California, San Diego.)
Year2015
Volume105
Issue2
Pages302-303
Publication date2015-02-01
Peer ReviewedYes
Open AccessNo
TypeARTICLE
VenueAmerican Journal of Public Health (JOURNAL)
Journal identifiersISSN: 0090-0036 • E-ISSN: 1541-0048
PublisherAmerican Public Health Association (PUBLISHER • US)
DOI10.2105/ajph.2014.302245
PMID25521877
OpenAlexW2003857844
LanguageEN
Citations received2
References cited12

We asked persons who inject drugs questions about HCV, including past testing and diagnosis followed by HCV testing. Of 540 participants, 145 (27%) were anti-HCV positive, but of those who were positive, only 46 (32%) knew about their infection. Asking about previous HCV testing results yielded better results than did asking about prior HCV diagnosis. Factors associated with knowing about HCV infection included older age, HIV testing, and drug treatment. Comprehensive approaches to educating and screening this population for HCV need implementation

Drug injection · Environmental health · Family medicine · Hepatitis C · Human immunodeficiency virus (HIV) · Injection drug use · Population · Hepatitis B Virus Studies · Hepatitis C virus research · HIV, Drug Use, Sexual Risk · Immunology · Medicine

Tools

Open DOISci-HubOpen Access